ASCO 2022 Conference Coverage
Video Player is loading.
10 seconds
Playback speed
Lecture Summary - ASCO 2022 Adjuvant Abemaciclib for High-risk Early Breast Cancer: Factors Increasing the Rate of Treatment Discontinuations in monarchE
By
ASCO 2022 Conference Coverage
FEATURING
Sara Tolaney
By
ASCO 2022 Conference Coverage
FEATURING
Sara Tolaney
Comments 0
Login to view comments.
Click here to Login
